From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
Supporting healthcare professionals with the latest evidence, clinical resources, and training on Doxy-PEP for STI prevention.
Responding to the interest in Doxy-PEP for STI prevention, ASHM supports healthcare professionals with up-to-date information, clinical resources, and training. In close collaboration with researchers, clinicians, and public health stakeholders to ensure the sector is informed and prepared for Doxy-PEP in STI prevention strategies.
Delivering education and clinical support to help healthcare professionals navigate the emerging role of Doxy-PEP in STI prevention.
Supporting a proactive and informed response as new prevention tools like Doxy-PEP gain attention across the sexual health sector.
Collaborating sector-wide to develop inclusive resources, training and awareness campaigns.
The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis.
2023 Consensus Statement on doxycycline prophylaxis (Doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual, and other men who have sex with men in Australia
This printable resource provides clients, patients, and the community with comprehensive, easy-to-understand information about Doxy-PEP, including what it is, who it’s for, how it’s taken, its effectiveness, side effects, and cost.
ASHM is conducting a series of 4 webinars on Doxy-PEP to support the workforce to implement Doxy-PEP in their practices. The first two webinars will help provide background information on Doxy-PEP, including how to use ASHM’s Doxy-PEP Decision-Making Tool during consultation. The second webinar, developed in collaboration with NACCHO, provides an overview of STI prevention for Aboriginal and Torres Strait Islander Communities, with a focus on Doxy-PEP for STI prevention.
Find up-to-date information, clinical resources, and training
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM